← Back to Dividend Calendar

Bristol-Myers Squibb Company

BMYNYSE

HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Market Cap

$121.69B

Revenue (TTM)

$48.19B

EBITDA

$19.12B

Profit Margin

14.6%

P/E Ratio

17.23

Earnings Growth (YoY)

1392.0%

Return on Equity

40.4%

Dividend Yield

4.1%

Upcoming Events (1)Past Events (0)

Earnings Report

Bristol-Myers Squibb

Pre-Market

Report Date:

Fiscal Period:

EPS Estimate:

Rev. Estimate:

Price Target:

Oct 29, 2026

Q3 2026

$1.73(prior yr: $1.63)

$12.6B

$67.22